Here's Why You Should Add Dr. Reddy's Stock to Your Portfolio

Dr. Reddy’s Laboratories (RDY) is a major player in the generic drugs markets. The company reports its financial performance under three operating segments — Global Generics, Pharmaceutical Services & Active Ingredients and Others.Let’s delve deeper to discuss four reasons why adding Dr. Reddy’s stock to your portfolio may prove beneficial in fiscal 2025.RDY Boasts a Strong Pipeline of Generic DrugsDr. Reddy’s enjoys a strong position in the generics market. As of Sept. 30, 2024, cumulatively, 80 generic fi ...